CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-β signaling
暂无分享,去创建一个
H. Lee | H-J Lee | S-J Kim | Suji Han | T. Kwak | K. Her | Y-H Cho | C. Choi | S. Hong | Y. Park | Y-S Kim | T-A Kim | S.-J. Kim | S-U Han | T-H Kwak | K H Her | Y-H Cho | C Choi | S Hong | Y S Park | Y-S Kim | T-A Kim | Y. Park
[1] Y. Bang,et al. Establishment and characterization of human gastric carcinoma cell lines , 1997, International journal of cancer.
[2] J. Massagué,et al. Controlling TGF- b signaling , 2000 .
[3] L. Wakefield,et al. TGF-β signaling: positive and negative effects on tumorigenesis , 2002 .
[4] K. Kinzler,et al. Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.
[5] C. Stanners. Cell Adhesion and Communication Mediated by the CEA Family , 1998 .
[6] A. Gazdar,et al. Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers , 1992, International journal of cancer.
[7] M. Neumaier,et al. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Roberts,et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β , 1999, The EMBO journal.
[9] S. von Kleist,et al. Cea expression of colorectal adenocarcinomas is correlated with their resistance against lak‐cell lysis , 1994, International journal of cancer.
[10] C. Stanners,et al. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. , 2000, Cancer research.
[11] M. Brattain,et al. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta. , 1988, Cancer research.
[12] S. Hammarström. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. , 1999, Seminars in cancer biology.
[13] Kathleen R. Cho,et al. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. , 1995, Cancer research.
[14] Keunchil Park,et al. Expression of Transforming Growth Factor β Type II Receptor Reduces Tumorigenicity in Human Gastric Cancer Cells , 1997 .
[15] S. Ergün,et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. , 2000, Molecular cell.
[16] Xin-Hua Feng,et al. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). , 2002, Molecular cell.
[17] Y. Bang,et al. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells , 1999, British Journal of Cancer.
[18] Hyeong-Rok Kim,et al. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients , 2000, Journal of surgical oncology.
[19] J. Reimann,et al. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 on Murine Dendritic Cells Is a Potent Regulator of T Cell Stimulation1 , 2001, The Journal of Immunology.
[20] J. Massagué,et al. Cell adhesion protein receptors as targets for transforming growth factor-β action , 1987, Cell.
[21] C. Stanners,et al. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. , 2002, Neoplasia.
[22] M. Sporn,et al. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[23] Y. Bang,et al. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer , 2004, Oncogene.
[24] Abraham Fuks,et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule , 1989, Cell.
[25] S. von Kleist,et al. The carcinoembryonic antigen (CEA) modulates effector‐target cell interaction by binding to activated lymphocytes , 1996, International journal of cancer.
[26] Phil Gold,et al. SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.
[27] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[28] F. Mitjans,et al. Leukocyte recruitment in colon cancer: role of cell adhesion molecules, nitric oxide, and transforming growth factor beta1. , 2002, Gastroenterology.
[29] S. Markowitz,et al. Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis , 2000 .
[30] A. Chevinsky. CEA in tumors of other than colorectal origin. , 1991, Seminars in surgical oncology.
[31] S. von Kleist,et al. Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation , 1998, European journal of immunology.
[32] Y. Sun,et al. Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. , 1999, Journal of cell science.
[33] J. Massagué,et al. Controlling TGF-β signaling , 2000, Genes & Development.
[34] T. Kuijpers,et al. CD66 nonspecific cross-reacting antigens are involved in neutrophil adherence to cytokine-activated endothelial cells , 1992, The Journal of cell biology.
[35] C. Stanners,et al. The Specificity for the Differentiation Blocking Activity of Carcinoembryonic Antigen Resides in Its Glycophosphatidyl-Inositol Anchor , 2000, The Journal of cell biology.